Cabio Biotech (Wuhan) Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 433.42 million compared to CNY 351.11 million a year ago. Net income was CNY 108.69 million compared to CNY 128.58 million a year ago.

Basic earnings per share from continuing operations was CNY 0.6429 compared to CNY 0.7643 a year ago.